{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T15:51:56Z","timestamp":1789487516622,"version":"build-2803163510"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":214,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007417","name":"The Paulo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007417","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007639","name":"Maire Taponen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007639","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002342","name":"Finnish Academy of Science and Letters","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003125","name":"Finnish Cultural Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010129","name":"Maud Kuistila Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Aging Brain"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.nbas.2026.100165","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:34:41Z","timestamp":1786026881000},"page":"100165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Change in brain glucose metabolism and cognition in amnestic MCI patients in relation to amyloid accumulation: A 3-year follow-up study"],"prefix":"10.1016","volume":"10","author":[{"given":"Elina","family":"Rauhala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarkko","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6996-9157","authenticated-orcid":false,"given":"Mira","family":"Karrasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-5662","authenticated-orcid":false,"given":"Olli","family":"Eskola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3308-1260","authenticated-orcid":false,"given":"Tuula","family":"Tolvanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Rajander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6369-0764","authenticated-orcid":false,"given":"Juha O.","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbas.2026.100165_bb0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.6971492","article-title":"Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique","volume":"212","author":"Greenberg","year":"1981","journal-title":"Science"},{"key":"10.1016\/j.nbas.2026.100165_bb0010","author":"Edison"},{"key":"10.1016\/j.nbas.2026.100165_bb0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","article-title":"FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease","volume":"36","author":"Mosconi","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nbas.2026.100165_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrneurol.2009.217","article-title":"The use of PET in Alzheimer disease","volume":"6","author":"Nordberg","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.nbas.2026.100165_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.06.015","article-title":"Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer\u2019s disease","volume":"33","author":"Kadir","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nbas.2026.100165_bb0030","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00259-008-0833-y","article-title":"Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer\u2019s disease","volume":"35","author":"Li","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nbas.2026.100165_bb0035","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","article-title":"MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET","volume":"63","author":"Mosconi","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.nbas.2026.100165_bb0040","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00259-012-2102-3","article-title":"Longitudinal imaging of Alzheimer pathology using [ 11C]PIB, [ 18F]FDDNP and [ 18F]FDG PET","volume":"39","author":"Ossenkoppele","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nbas.2026.100165_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00251","article-title":"Longitudinal assessment of amyloid-\u03b2 deposition by [18F]-Flutemetamol PET imaging compared with [11C]-PIB across the spectrum of Alzheimer\u2019s disease","volume":"11","author":"Hatashita","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nbas.2026.100165_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/s13550-022-00928-5","article-title":"Change in brain amyloid load and cognition in patients with amnestic mild cognitive impairment: a 3-year follow-up study","volume":"12","author":"Rauhala","year":"2022","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nbas.2026.100165_bb0055","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jamaneurol.2018.0894","article-title":"Use of flutemetamol F18-labeled positron emission tomography and other biomarkers to assess risk of clinical progression in patients with amnestic mild cognitive impairment","volume":"75","author":"Wolk","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.nbas.2026.100165_bb0060","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1007\/s00259-013-2478-8","article-title":"PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment","volume":"40","author":"Br\u00fcck","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nbas.2026.100165_bb0065","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbas.2026.100165_bb0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1212\/WNL.0b013e318212015e","article-title":"Amyloid PET imaging in patients with mild cognitive impairment: a 2-year follow-up study","volume":"76","author":"Koivunen","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nbas.2026.100165_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbas.2026.100165_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nbas.2026.100165_bb0085","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2967\/jnumed.118.219097","article-title":"Principal components analysis of brain metabolism predicts development of Alzheimer dementia","volume":"60","author":"Blazhenets","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nbas.2026.100165_bb0090","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1212\/01.WNL.0000163856.13524.08","article-title":"Reduced hippocampal metabolism in MCI and AD: automated FDG-PET image analysis","volume":"64","author":"Mosconi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbas.2026.100165_bb0095","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00259-014-2919-z","article-title":"Cortical hypermetabolism in MCI subjects: a compensatory mechanism?","volume":"42","author":"Ashraf","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nbas.2026.100165_bb0100","doi-asserted-by":"crossref","first-page":"14770","DOI":"10.1523\/JNEUROSCI.3669-09.2009","article-title":"Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve","volume":"29","author":"Cohen","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.nbas.2026.100165_bb0105","article-title":"FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels","volume":"12","author":"Rubinski","year":"2020","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10.1016\/j.nbas.2026.100165_bb0110","series-title":"J Alzheimers Dis [internet]","first-page":"123","article-title":"Long-term interrelationship between brain metabolism and amyloid deposition in mild cognitive impairment","volume":"vol. 48","author":"Kemppainen","year":"2015"},{"key":"10.1016\/j.nbas.2026.100165_bb0115","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/cercor\/bhr271","article-title":"CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects","volume":"22","author":"Ewers","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.nbas.2026.100165_bb0120","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","article-title":"Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI","volume":"32","author":"Landau","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.nbas.2026.100165_bb0125","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.2967\/jnumed.112.116137","article-title":"Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET","volume":"54","author":"Shokouhi","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nbas.2026.100165_bb0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1474-4422(18)30029-2","article-title":"Cognitive and neuroimaging features and brain \u03b2-amyloidosis in individuals at risk of Alzheimer\u2019s disease (INSIGHT-preAD): a longitudinal observational study","volume":"17","author":"Dubois","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbas.2026.100165_bb0135","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3233\/JAD-220585","article-title":"Monitoring Alzheimer\u2019s disease progression in mild cognitive impairment stage using machine learning-based FDG-PET classification methods","volume":"89","author":"Beheshti","year":"2022","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.nbas.2026.100165_bb0140","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11357-023-01031-w","article-title":"Early cerebral amyloid-\u03b2 accumulation and hypermetabolism are associated with subtle cognitive deficits before accelerated cerebral atrophy","volume":"vol. 46","author":"Bakhtiari","year":"2024","journal-title":"Geroscience"},{"key":"10.1016\/j.nbas.2026.100165_bb0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/j.nbas.2026.100165_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer\u2019s disease","author":"Jack","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nbas.2026.100165_bb0155","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jalz.2012.01.006","article-title":"Amyloid positron emission tomography with 18F-flutemetamol and structural magnetic resonance imaging in the classification of mild cognitive impairment and Alzheimer\u2019s disease","volume":"9","author":"Duara","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.nbas.2026.100165_bb0160","series-title":"Wechsler adult intelligence scale-revised (WAIS-R)","author":"Wechsler","year":"1981"},{"key":"10.1016\/j.nbas.2026.100165_bb0165","series-title":"WMS-R k\u00e4sikirja [manual of the Finnish version of WMS-R]","author":"Wechsler","year":"1996"},{"key":"10.1016\/j.nbas.2026.100165_bb0170","series-title":"Multilingual aphasia examination","author":"Benton","year":"1976"},{"key":"10.1016\/j.nbas.2026.100165_bb0175","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","article-title":"Validity of the trail making test as an indicator of organic brain damage","volume":"8","author":"Reitan","year":"1958","journal-title":"Percept Mot Skills"},{"key":"10.1016\/j.nbas.2026.100165_bb0180","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/WNL.44.4.609","article-title":"The consortium to establish a registry for Alzheimer\u2019s disease (CERAD). Part V. A normative study of the neuropsychological battery","volume":"44","author":"Welsh","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.nbas.2026.100165_bb0185","series-title":"Neuropsychological assessment","author":"Lezak","year":"2012"},{"key":"10.1016\/j.nbas.2026.100165_bb0190","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3233\/JAD-190691","article-title":"Midlife insulin resistance as a predictor for late-life cognitive function and cerebrovascular lesions","volume":"72","author":"Toppala","year":"2019","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.nbas.2026.100165_bb0195","doi-asserted-by":"crossref","first-page":"5394","DOI":"10.1118\/1.3635220","article-title":"Physical performance of the new hybrid PETCT Discovery-690","volume":"38","author":"Bettinardi","year":"2011","journal-title":"Med Phys"},{"key":"10.1016\/j.nbas.2026.100165_bb0200","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","article-title":"An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest","volume":"31","author":"Desikan","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbas.2026.100165_bb0205","author":"Scheinin"},{"key":"10.1016\/j.nbas.2026.100165_bb0210","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/01.wnl.0000269790.05105.16","article-title":"What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?","volume":"69","author":"Jagust","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.nbas.2026.100165_bb0215","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.neuroimage.2010.02.064","article-title":"Twelve-month metabolic declines in probable Alzheimer\u2019s disease and amnestic mild cognitive impairment assessed using an empirically pre-defined statistical region-of-interest: findings from the Alzheimer\u2019s disease neuroimaging initiative","volume":"51","author":"Chen","year":"2010","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbas.2026.100165_bb0220","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/ana.23650","article-title":"Amyloid deposition, hypometabolism, and longitudinal cognitive decline","volume":"72","author":"Landau","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nbas.2026.100165_bb0225","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"\u03b2-Amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer\u2019s disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbas.2026.100165_bb0230","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/1533317510382286","article-title":"Patterns of cognitive decline, conversion rates, and predictive validity for 3 models of MCI","volume":"25","author":"Ritchie","year":"2010","journal-title":"Am J Alzheimers Dis Other Dement"},{"key":"10.1016\/j.nbas.2026.100165_bb0235","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1212\/WNL.0b013e318288690c","article-title":"Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI","volume":"80","author":"Vos","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.nbas.2026.100165_bb0240","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/awp132","article-title":"Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer\u2019s disease","volume":"132","author":"Fouquet","year":"2009","journal-title":"Brain"}],"container-title":["Aging Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958926000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589958926000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T14:47:42Z","timestamp":1789483662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589958926000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":48,"alternative-id":["S2589958926000101"],"URL":"https:\/\/doi.org\/10.1016\/j.nbas.2026.100165","relation":{},"ISSN":["2589-9589"],"issn-type":[{"value":"2589-9589","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in brain glucose metabolism and cognition in amnestic MCI patients in relation to amyloid accumulation: A 3-year follow-up study","name":"articletitle","label":"Article Title"},{"value":"Aging Brain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbas.2026.100165","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100165"}}